» Authors » J W Dallinga

J W Dallinga

Explore the profile of J W Dallinga including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 31
Citations 547
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Smolinska A, Baranska A, Dallinga J, Mensink R, Baumgartner S, van de Heijning B, et al.
Sci Rep . 2019 Jan; 9(1):554. PMID: 30679671
Infant formulae have been used since decades as an alternative to or a complement to human milk. Human milk, the "gold standard" of infant nutrition, has been studied for its...
2.
Fijten R, Smolinska A, Shi Q, Pachen D, Dallinga J, Boots A, et al.
J Breath Res . 2017 Oct; 12(2):027101. PMID: 28972195
Genotoxic carcinogens significantly damage cells and tissues by targeting macromolecules such as proteins and DNA, but their mechanisms of action and effects on human health are diverse. Consequently, determining the...
3.
Smolinska A, Bodelier A, Dallinga J, Masclee A, Jonkers D, van Schooten F, et al.
Aliment Pharmacol Ther . 2017 Feb; 45(9):1244-1254. PMID: 28239876
Background: To optimise treatment of ulcerative colitis (UC), patients need repeated assessment of mucosal inflammation. Current non-invasive biomarkers and clinical activity indices do not accurately reflect disease activity in all...
4.
Blanchet L, Smolinska A, Baranska A, Tigchelaar E, Swertz M, Zhernakova A, et al.
J Breath Res . 2017 Feb; 11(1):016013. PMID: 28140379
Background: Thousands of endogenous and exogenous volatile organic compounds (VOCs) are excreted in each breath. Inflammatory and deviant metabolic processes affect the level of endogeneous VOCs, which can serve as...
5.
Baranska A, Mujagic Z, Smolinska A, Dallinga J, Jonkers D, Tigchelaar E, et al.
Aliment Pharmacol Ther . 2016 May; 44(1):45-56. PMID: 27136066
Background: The diagnosis of irritable bowel syndrome (IBS) is challenging because of its heterogeneity and multifactorial pathophysiology. No reliable biomarkers of IBS have been identified so far. Aims: In a...
6.
van Vliet D, Smolinska A, Jobsis Q, Rosias P, Muris J, Dallinga J, et al.
J Breath Res . 2016 Feb; 10(1):016014. PMID: 26893372
The relationship between exhaled inflammatory markers and asthma control in children is unclear. To explore the association between inflammatory markers in exhaled breath (fractional nitric oxide (FeNO), volatile organic compounds...
7.
Baranska A, Smolinska A, Boots A, Dallinga J, Schooten F
J Breath Res . 2015 Oct; 9(4):047102. PMID: 26469548
Exhaled breath has proven to be a valuable source of information about human bodies. Subtle differences between volatile organic compounds (VOCs) formed endogenously can be detected and become a base...
8.
Boots A, Smolinska A, van Berkel J, Fijten R, Stobberingh E, Boumans M, et al.
J Breath Res . 2014 Apr; 8(2):027106. PMID: 24737039
The identification of specific volatile organic compounds (VOCs) produced by microorganisms may assist in developing a fast and accurate methodology for the determination of pulmonary bacterial infections in exhaled air....
9.
Smolinska A, Hauschild A, Fijten R, Dallinga J, Baumbach J, Schooten F
J Breath Res . 2014 Apr; 8(2):027105. PMID: 24713999
We define breathomics as the metabolomics study of exhaled air. It is a strongly emerging metabolomics research field that mainly focuses on health-related volatile organic compounds (VOCs). Since the amount...
10.
Kolk A, van Berkel J, Claassens M, Walters E, Kuijper S, Dallinga J, et al.
Int J Tuberc Lung Dis . 2012 Apr; 16(6):777-82. PMID: 22507235
Setting: Cape Town, South Africa. Objectives: We investigated the potential of breath analysis by gas chromatography-mass spectrometry (GC-MS) to discriminate between samples collected prospectively from patients with suspected tuberculosis (TB)....